TC Medical(SH:600763) Sou Hu Cai Jing·2025-12-10 11:53Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Tongce Medical (600763), indicating a slight decline in stock price and mixed capital flow on December 10, 2025 [1][2] - As of December 10, 2025, Tongce Medical's stock closed at 41.18 yuan, down 0.77%, with a turnover rate of 1.01% and a trading volume of 45,300 hands, resulting in a transaction amount of 186 million yuan [1] - The capital flow data on December 10 shows a net outflow of 18.96 million yuan from main funds, accounting for 10.19% of the total transaction amount, while retail investors saw a net inflow of 10.10 million yuan, representing 5.43% of the total [1] Group 2 - In the third quarter of 2025, Tongce Medical reported a main revenue of 842 million yuan, an increase of 2.34% year-on-year, and a net profit attributable to shareholders of 192 million yuan, up 2.31% year-on-year [2] - The company's financial metrics for the first three quarters of 2025 include a total revenue of 2.29 billion yuan, a net profit of 514 million yuan, and a debt ratio of 25.1% [2] - The average target price set by institutions for Tongce Medical over the past 90 days is 52.88 yuan, with 4 buy ratings and 3 hold ratings from 7 institutions [2]